These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31682300)

  • 21. The vitronectin binding area of plasminogen activator inhibitor-1, mapped by mutagenesis and protection against an inactivating organochemical ligand.
    Jensen JK; Wind T; Andreasen PA
    FEBS Lett; 2002 Jun; 521(1-3):91-4. PubMed ID: 12067733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
    Deng G; Curriden SA; Wang S; Rosenberg S; Loskutoff DJ
    J Cell Biol; 1996 Sep; 134(6):1563-71. PubMed ID: 8830783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin.
    Deng G; Curriden SA; Hu G; Czekay RP; Loskutoff DJ
    J Cell Physiol; 2001 Oct; 189(1):23-33. PubMed ID: 11573201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A deletion mutant of vitronectin lacking the somatomedin B domain exhibits residual plasminogen activator inhibitor-1-binding activity.
    Schar CR; Blouse GE; Minor KH; Peterson CB
    J Biol Chem; 2008 Apr; 283(16):10297-309. PubMed ID: 18174166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor.
    Seiffert D; Ciambrone G; Wagner NV; Binder BR; Loskutoff DJ
    J Biol Chem; 1994 Jan; 269(4):2659-66. PubMed ID: 7507927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mechanism for assembly of complexes of vitronectin and plasminogen activator inhibitor-1 from sedimentation velocity analysis.
    Minor KH; Schar CR; Blouse GE; Shore JD; Lawrence DA; Schuck P; Peterson CB
    J Biol Chem; 2005 Aug; 280(31):28711-20. PubMed ID: 15905170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disulfide bonding arrangements in active forms of the somatomedin B domain of human vitronectin.
    Kamikubo Y; De Guzman R; Kroon G; Curriden S; Neels JG; Churchill MJ; Dawson P; Ołdziej S; Jagielska A; Scheraga HA; Loskutoff DJ; Dyson HJ
    Biochemistry; 2004 Jun; 43(21):6519-34. PubMed ID: 15157085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solution structure of recombinant somatomedin B domain from vitronectin produced in Pichia pastoris.
    Kjaergaard M; Gårdsvoll H; Hirschberg D; Nielbo S; Mayasundari A; Peterson CB; Jansson A; Jørgensen TJ; Poulsen FM; Ploug M
    Protein Sci; 2007 Sep; 16(9):1934-45. PubMed ID: 17766387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissecting molecular details and functional effects of the high-affinity copper binding site in plasminogen activator Inhibitor-1.
    Chu Y; Bucci JC; Peterson CB
    Protein Sci; 2021 Mar; 30(3):597-612. PubMed ID: 33345392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration.
    Zhou A; Huntington JA; Pannu NS; Carrell RW; Read RJ
    Nat Struct Biol; 2003 Jul; 10(7):541-4. PubMed ID: 12808446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The reduced, denatured somatomedin B domain of vitronectin refolds into a stable, biologically active molecule.
    Kamikubo Y; Kroon G; Curriden SA; Dyson HJ; Loskutoff DJ
    Biochemistry; 2006 Mar; 45(10):3297-306. PubMed ID: 16519524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-range allostery mediates the regulation of plasminogen activator inhibitor-1 by cell adhesion factor vitronectin.
    Kihn K; Marchiori E; Spagnolli G; Boldrini A; Terruzzi L; Lawrence DA; Gershenson A; Faccioli P; Wintrode PL
    J Biol Chem; 2022 Dec; 298(12):102652. PubMed ID: 36444882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights into the size and stoichiometry of the plasminogen activator inhibitor type-1.vitronectin complex.
    Podor TJ; Shaughnessy SG; Blackburn MN; Peterson CB
    J Biol Chem; 2000 Aug; 275(33):25402-10. PubMed ID: 10821827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition.
    Thompson LC; Goswami S; Ginsberg DS; Day DE; Verhamme IM; Peterson CB
    Protein Sci; 2011 Feb; 20(2):353-65. PubMed ID: 21280127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metals affect the structure and activity of human plasminogen activator inhibitor-1. II. Binding affinity and conformational changes.
    Thompson LC; Goswami S; Peterson CB
    Protein Sci; 2011 Feb; 20(2):366-78. PubMed ID: 21280128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1.
    Madsen JB; Dupont DM; Andersen TB; Nielsen AF; Sang L; Brix DM; Jensen JK; Broos T; Hendrickx ML; Christensen A; Kjems J; Andreasen PA
    Biochemistry; 2010 May; 49(19):4103-15. PubMed ID: 20387790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assignment of the four disulfides in the N-terminal somatomedin B domain of native vitronectin isolated from human plasma.
    Horn NA; Hurst GB; Mayasundari A; Whittemore NA; Serpersu EH; Peterson CB
    J Biol Chem; 2004 Aug; 279(34):35867-78. PubMed ID: 15173163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin.
    Arroyo De Prada N; Schroeck F; Sinner EK; Muehlenweg B; Twellmeyer J; Sperl S; Wilhelm OG; Schmitt M; Magdolen V
    Eur J Biochem; 2002 Jan; 269(1):184-92. PubMed ID: 11784312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of helix F in plasminogen activator inhibitor-1.
    Vleugels N; Gils A; Bijnens AP; Knockaert I; Declerck PJ
    Biochim Biophys Acta; 2000 Jan; 1476(1):20-6. PubMed ID: 10606763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of the amino-acid composition of the shutter region of plasminogen activator inhibitor-1 for its transitions to latent and substrate forms.
    Hansen M; Busse MN; Andreasen PA
    Eur J Biochem; 2001 Dec; 268(23):6274-83. PubMed ID: 11733024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.